calendar
3,760 catalysts · 3,728 phase readout · 2,103 8k filing · 276 earnings · 172 phase 2 completion · 152 grant · 133 drug shortage
3,760 catalysts · 3,728 phase readout · 2,103 8k filing · 276 earnings · 172 phase 2 completion · 152 grant · 133 drug shortage
no tagged catalysts yet
Supplement type: Normal 180 Day Track No User Fee. Product code: MJO. Advisory committee: OR. Decision: APPR
Supplement type: 30-Day Notice. Product code: MDP. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: QZK. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MFE. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: MCM. Advisory committee: EN. Decision: OK30
Supplement type: 30-Day Notice. Product code: NZK. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30
Supplement type: 30-Day Notice. Product code: MOZ. Advisory committee: OR. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NPT. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MCX. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: OAD. Advisory committee: CV. Decision: OK30
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: MWG. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QZH. Advisory committee: TX. Decision: APPR
Supplement type: Real-Time Process. Product code: NIK. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: NAW. Advisory committee: RA. Decision: APPR
Supplement type: 30-Day Notice. Product code: MRA. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: QPY. Advisory committee: PM. Decision: OK30
Supplement type: Real-Time Process. Product code: LWP. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: DSQ. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: NPW. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QFV. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: QQK. Advisory committee: GU. Decision: APPR
Supplement type: 30-Day Notice. Product code: NJL. Advisory committee: OR. Decision: OK30
Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain
Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain
Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma
Sponsor: The University of Queensland. Phase: NA. Conditions: Blood Culture Contamination, Infection
Sponsor: Mayo Clinic. Phase: . Conditions: Spontaneous Coronary Artery Dissection
Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder
Sponsor: October 6 University. Phase: NA. Conditions: Cerebral Palsy
Sponsor: Liverpool School of Tropical Medicine. Phase: NA. Conditions: Crimean-Congo Haemorrhagic Fever
Sponsor: Eilean Therapeutics AU Pty Ltd. Phase: PHASE1. Conditions: Healthy Volunteers
Sponsor: Chandan Sen. Phase: NA. Conditions: Wound Heal, Wound Infection, Wound Healing Delayed, Wound of Skin, Infections
Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Neuropsychiatric Disorder, Neurological Disorder, Neurodevelopmental Disorder, Sleep
Sponsor: University of Washington. Phase: NA. Conditions: Mental Health Disorder
Sponsor: Nanchang University. Phase: NA. Conditions: Natural Orifice Specimen Extraction Surgery, Robotic Surgery, Short-term Outcomes
Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Endometrial Carcinoma
Sponsor: Alumis Inc. Phase: PHASE1. Conditions: Healthy Volunteer
Sponsor: Hu Liangshuo. Phase: . Conditions: Liver Transplantation, Hepatocellular Carcinoma (HCC), Tyrosine Kinase Inhibitor, Survival Rate
Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Immune Thrombocytopenia, Treatment